Overview

iota Biosciences develops ultra-small, implantable bioelectronic devices that monitor and modulate bodily signals from inside the body. Their neural dust concept uses ultrasound to power these tiny implants and to carry data, enabling millimeter-scale devices implanted with minimal invasiveness. This approach eliminates bulky batteries and wired connections, allowing deep-tissue sensing and precise neuromodulation for real-time, closed-loop therapies. Astellas acquired Iota in 2020 to accelerate clinical development across areas like bladder disorders, autoimmune diseases, cancer, and neurological conditions.